Tivity Health (NASDAQ:TVTY)‘s stock had its “sell” rating reiterated by Zacks Investment Research in a research note issued on Saturday.

According to Zacks, “Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. “

Several other research analysts have also weighed in on TVTY. Jefferies Group restated a “buy” rating and set a $46.00 price objective on shares of Tivity Health in a research note on Monday, September 25th. ValuEngine lowered shares of Tivity Health from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. SunTrust Banks restated a “buy” rating and set a $46.00 price objective on shares of Tivity Health in a research note on Thursday, October 12th. Chardan Capital restated a “neutral” rating and set a $44.00 price objective (up from $40.00) on shares of Tivity Health in a research note on Friday, October 27th. Finally, Oppenheimer boosted their price objective on shares of Tivity Health from $47.00 to $50.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $46.25.

Tivity Health (TVTY) opened at $36.35 on Friday. The firm has a market cap of $1,442.06, a PE ratio of 24.56, a PEG ratio of 1.94 and a beta of 0.18. Tivity Health has a 52 week low of $20.60 and a 52 week high of $48.50. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60.

Tivity Health (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.10. The company had revenue of $137.70 million for the quarter, compared to analyst estimates of $137.95 million. Tivity Health had a net margin of 11.45% and a return on equity of 30.23%. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. research analysts predict that Tivity Health will post 1.6 earnings per share for the current fiscal year.

In related news, insider Mary Flipse sold 5,000 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $48.11, for a total value of $240,550.00. Following the transaction, the insider now owns 45,167 shares in the company, valued at approximately $2,172,984.37. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Glenn Hargreaves sold 5,805 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $45.15, for a total transaction of $262,095.75. Following the completion of the transaction, the chief accounting officer now owns 44,448 shares in the company, valued at approximately $2,006,827.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 875,892 shares of company stock worth $31,815,642. 8.42% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Flinton Capital Management LLC grew its stake in Tivity Health by 63.5% in the 2nd quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock valued at $139,000 after buying an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC grew its position in shares of Tivity Health by 69.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after purchasing an additional 1,464 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Tivity Health during the 3rd quarter worth approximately $210,000. Crossmark Global Holdings Inc. acquired a new position in shares of Tivity Health during the 3rd quarter worth approximately $279,000. Finally, Piedmont Investment Advisors LLC acquired a new position in shares of Tivity Health during the 2nd quarter worth approximately $290,000.

TRADEMARK VIOLATION WARNING: This piece of content was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://theolympiareport.com/2018/01/06/zacks-investment-research-reiterates-sell-rating-for-tivity-health-tvty.html.

About Tivity Health

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.